Table 4.

Biochemical parameters before and after the 8-week intervention.

Variables	Pre	Post	Change	p-Value	Effect Size
Bone turnover markers
CTx (ng/mL)	0.40 ± 0.16	0.37 ± 0.14	−0.03 ± 0.09	0.037	0.306
Osteocalcin (ng/mL)	16.33 ± 4.84	14.25 ± 4.46	−2.08 ± 3.09	<0.0001 *	0.673
Hormones
E2 (pg/mL)	35.33 ± 154.83	12.90 ± 22.99	−22.43 ± 153.80	0.312	0.146
FSH (mIU/mL)	62.52 ± 31.30	59.75 ± 30.46	−2.77 ± 10.02	0.059	0.277
Lipid profile
TG (mg/dL)	120.65 ± 67.47	112.06 ± 106.28	−8.59 ± 80.68	0.460	0.106
TC (mg/dL)	209.78 ± 39.98	199.69 ± 43.38	−10.08 ± 30.51	0.025	0.330
HDL-C (mg/dL)	58.88 ± 13.62	59.92 ± 13.27	1.04 ± 8.78	0.411	0.119
LDL-C (mg/dL)	134.69 ± 37.13	124.63 ± 37.34	−10.06 ± 26.81	0.012	0.375
LDL-C/HDL-C	2.41 ± 0.84	2.16 ± 0.77	−0.25 ± 0.63	0.009	0.387
TC/HDL-C	3.74 ± 1.09	3.46 ± 1.01	−0.28 ± 0.84	0.025	0.330
hs-CRP (mg/dL)	0.08 ± 0.08	0.12 ± 0.17	0.04 ± 0.16	0.113	0.230
Lp(a) (mg/dL)	21.70 ± 20.58	21.99 ± 19.78	0.28 ± 5.35	0.706	0.054
ApoA1 (mg/dL)	161.50 ± 22.03	149.19 ± 23.98	−12.31 ± 18.29	<0.0001 *	0.673
ApoB (mg/dL)	104.65 ± 24.39	96.20 ± 22.09	−8.45 ± 16.82	0.001 *	0.502
ApoB/ApoA1	1.65 ± 0.54	1.65 ± 0.54	0.001 ± 0.014	0.955	0.001
Glycemic parameters
Glucose (mg/dL)	95.76 ± 15.62	91.31 ± 7.95	−4.45 ± 16.47	0.065	0.270
Insulin (μU/mL)	8.56 ± 5.16	7.06 ± 3.47	−1.50 ± 4.98	0.040	0.301

Data are represented as mean ± standard deviations. Asterisk (*) indicates if the p-value was significant even after Bonferroni correction for multiple comparisons (corrected p-value: 0.05/31 = 0.002). CTx, C-terminal telopeptide of type I collagen; E2, Estradiol; FSH, Follicle-stimulating hormone; TG, Triglyceride; TC, Total cholesterol; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; LP(a), Lipoprotein(a); ApoA1, Apoprotein A1; ApoB, Apoprotein B.